(Q40397376)

20 September 2017

1 reference

title

Survey on the pharmacodynamics of the new antipsychotic risperidone (English)

1 reference

20 September 2017

1 reference

A A Megens

1

1 reference

20 September 2017

F H Awouters

2

1 reference

20 September 2017

A Schotte

3

1 reference

20 September 2017

T F Meert

4

1 reference

20 September 2017

C Dugovic

5

1 reference

20 September 2017

C J Niemegeers

6

1 reference

20 September 2017

J E Leysen

7

1 reference

20 September 2017

1 February 1994

1 reference

20 September 2017

15

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

20 September 2017

114

1 reference

20 September 2017

9-23

1 reference

20 September 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02245439

20 September 2017

0 references

cites work

Further evidence of abnormal non-rapid-eye-movement sleep in schizophrenia.

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245439

The dopamine hypothesis of schizophrenia: a review

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245439

An anatomy of schizophrenia?

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02245439

Molecular biology of the dopamine receptors

21 January 2018

1 reference

12 December 2020

Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine

1 reference

12 December 2020

Effect of drugs influencing central serotonergic mechanisms on haloperidol-induced catalepsy

1 reference

12 December 2020

Comparison of in vitro binding properties of a series of dopamine antagonists and agonists for cloned human dopamine D2S and D2L receptors and for D2 receptors in rat striatal and mesolimbic tissues, using [125I] 2'-iodospiperone.

1 reference

12 December 2020

Dopamine receptor binding in the corpus striatum of mammalian brain

1 reference

12 December 2020

Pharmacology of risperidone (R 64 766), a new antipsychotic with serotonin-S2 and dopamine-D2 antagonistic properties.

1 reference

12 December 2020

Behavioral aspects of serotonin-dopamine interaction in the monkey

1 reference

12 December 2020

Effects of atypical antipsychotic agents on social behavior in rodents

1 reference

12 December 2020

Effects of the 5-HT2 receptor antagonist, ritanserin, on biogenic amines in the rat nucleus accumbens

1 reference

12 December 2020

Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist

1 reference

12 December 2020

Antischizophrenic drugs: affinity for muscarinic cholinergic receptor sites in the brain predicts extrapyramidal effects

1 reference

12 December 2020

Binding of antipsychotic drugs at alpha 1A- and alpha 1B-adrenoceptors: risperidone is selective for the alpha 1B-adrenoceptors.

1 reference

12 December 2020

Binding of typical and atypical antipsychotic agents to transiently expressed 5-HT1C receptors

1 reference

12 December 2020

[Study by the intracerebral microdialysis method of the effects of atypical neuroleptics and anxiolytics on striatal release and metabolism of dopamine in awake rats]

1 reference

12 December 2020

Behavioral effects of D1 and D2 dopamine receptor antagonists in squirrel monkeys

1 reference

12 December 2020

Tolerability and therapeutic effect of clozapine. A retrospective investigation of 216 patients treated with clozapine for up to 12 years

1 reference

12 December 2020

Psychiatric adverse reactions to methysergide

1 reference

12 December 2020

Antagonistic effect of cyproheptadine on neuroleptic-induced catalepsy

1 reference

12 December 2020

Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents

1 reference

12 December 2020

In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone

1 reference

12 December 2020

Minireview A systematic study of the pharmacological activities of dopamine antagonists

1 reference

12 December 2020

IS IT POSSIBLE TO PREDICT THE CLINICAL EFFECTS OF NEUROLEPTIC DRUGS (MAJOR TRANQUILLIZERS) FROM ANIMAL DATA?I. "NEUROLEPTIC ACTIVITY SPECTRA" FOR RATS

1 reference

12 December 2020

Stimulation by risperidone of rat prolactin secretion in vivo and in cultured pituitary cells in vitro

1 reference

12 December 2020

Effect of various factors on serotonin-induced Ca2+ response in human platelets

1 reference

12 December 2020

Interactions between the argininyl moieties of neurotensin and the catechol protons of dopamine.

1 reference

12 December 2020

Functional interaction between serotonin-S2 and dopamine-D2 neurotransmission as revealed by selective antagonism of hyper-reactivity to tryptamine and apomorphine

1 reference

12 December 2020

The third dopamine receptor (D3) as a novel target for antipsychotics

1 reference

12 December 2020

Interaction of antipsychotic drugs with neurotransmitter receptor sites in vitro and in vivo in relation to pharmacological and clinical effects: role of 5HT2 receptors.

1 reference

12 December 2020

5-HT2 receptor blockade by ICI 169,369 and other 5-HT2 antagonists modulates the effects of D-2 dopamine receptor blockade

1 reference

12 December 2020

Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.

1 reference

12 December 2020

Neuroleptic affinities for human brain receptors and their use in predicting adverse effects

1 reference

12 December 2020

Sleep disorders in patients with severe mental depression: Double-blind placebo-controlled evaluation of the value of pipamperone (Dipiperon®)

1 reference

12 December 2020

Differential effects of the new antipsychotic risperidone on sleep and wakefulness in the rat.

1 reference

12 December 2020

Biochemical profile of risperidone, a new antipsychotic

1 reference

12 December 2020

Multiple human D5 dopamine receptor genes: a functional receptor and two pseudogenes

1 reference

12 December 2020

Application of drug discrimination with drugs of abuse to develop new therapeutic agents

1 reference

12 December 2020

Serotonergic component of neuroleptic receptors

1 reference

12 December 2020

Effects of antipsychotic drugs on serotonin receptors

1 reference

12 December 2020

A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients

1 reference

12 December 2020

Behavioral disinhibition and depression in amphetaminized rats: a comparison of risperidone, ocaperidone and haloperidol

1 reference

12 December 2020

The effect of serotonergic agents on haloperidol-induced catalepsy

1 reference

12 December 2020

A multicentric evaluation of pimozide (Orap) in patients who usually would take tranquillizers

1 reference

12 December 2020

Receptor occupancy by ritanserin and risperidone measured using ex vivo autoradiography

1 reference

12 December 2020

Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity

1 reference

12 December 2020

Metoclopramide and sulpiride as selective blocking agents of pre- and postsynaptic dopamine receptors

1 reference

12 December 2020

A drug discrimination analysis of lysergic acid diethylamide (LSD): in vivo agonist and antagonist effects of purported 5-hydroxytryptamine antagonists and of pirenperone, a LSD-antagonist.

1 reference

12 December 2020

Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroin

1 reference

12 December 2020

Comparison of the effects of haloperidol, remoxipride and raclopride on "pre"- and postsynaptic dopamine receptors in the rat brain

1 reference

12 December 2020

Development of psychiatric illness in drug abusers. Possible role of drug preference

1 reference

12 December 2020

Binding of typical and atypical antipsychotics to 5-HT1C and 5-HT2 sites: clozapine potently interacts with 5-HT1C sites

1 reference

12 December 2020

Differential sensitivity of two dopaminergic structures in rat brain to haloperidol and to clozapine

1 reference

12 December 2020

Prazosin, a specific alpha1-noradrenergic receptor antagonist, has no effect on symptoms but increases autonomic arousal in schizophrenic patients

1 reference

12 December 2020

Assessment of Low Dosage Haloperidol in Anxiety States

1 reference

12 December 2020

The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs?

1 reference

12 December 2020

EFFECT OF CHLORPROMAZINE OR HALOPERIDOL ON FORMATION OF 3METHOXYTYRAMINE AND NORMETANEPHRINE IN MOUSE BRAIN.

1 reference

12 December 2020

Interaction between cholinergic and catecholaminergic neurones in rat brain.

1 reference

12 December 2020

Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

1 reference

12 December 2020

Serotonin-S2 receptor binding sites and functional correlates

1 reference

12 December 2020

Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography

1 reference

12 December 2020

Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values

1 reference

12 December 2020

Differential effects of the new antipsychotic risperidone on large and small motor movements in rats: a comparison with haloperidol

1 reference

12 December 2020

Clozapine--a new antipsychotic agent.

1 reference

12 December 2020

Comparison of the effects of various typical and atypical antipsychotic drugs on the suppressant action of 2-methylserotonin on medial prefrontal cortical cells in the rat

1 reference

12 December 2020

Pharmacological profile of the new potent neuroleptic ocaperidone (R 79,598).

1 reference

12 December 2020

Serotonergic involvement with neuroleptic catalepsy

1 reference

12 December 2020

Pipamperone (Dipiperon) in the treatment of behaviour disorders. A large-scale multicentre evaluation

1 reference

12 December 2020

Brain receptors for antipsychotic drugs and dopamine: direct binding assays

1 reference

12 December 2020

Central serotonin antagonist activity of a number of phenothiazines

1 reference

12 December 2020

Risperidone (R 64 766), a potent and complete LSD antagonist in drug discrimination by rats.

1 reference

12 December 2020

Noncataleptogenic, centrally acting dopamine D-2 and serotonin 5-HT2 antagonists within a series of 3-substituted 1-(4-fluorophenyl)-1H-indoles

1 reference

12 December 2020

Extrapyramidal reactions and amine metabolites in cerebrospinal fluid during haloperidol and clozapine treatment of schizophrenic patients

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02245439

1 reference

Dimensions Publication ID

20 September 2017

0 references

1 reference